Valuation as at 2026-08-29 · see also the ASX 300 Most Undervalued screen
About Appen Limited
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application.
Source: Yahoo Finance company profile · factual description, not KashVector commentary
Appen Limited APX.AX
Technology · Information Technology Services
Appen Limited's price & financial trends
Annual reporting periods — this market does not have reliable quarterly data on Yahoo (either it isn't required, or coverage is incomplete), so annual is the most granular consistent series across free cash flow and dividends.
Data as at 2026-08-29
Share price · last 2 years
Earnings per share (diluted) Per year
Free cash flow Per year
Dividend per share
No dividend history available.
Value investing scale · Buffett · Dalio · Graham
4 criteria had no data
Intrinsic value estimate · 5-year forecast
Assumptions used in this valuation
Every input below is either fetched live from Yahoo Finance or a documented default — nothing is hidden.
| Bear | Base | Bull | |
|---|---|---|---|
| 5-yr FCF growth | 3.4% | 6.7% | 10.1% |
| Terminal growth | 2.5% | 2.5% | 2.5% |
| WACC (discount rate) | 15.88% | 14.88% | 13.88% |
Cost of Equity = Risk-free rate + Beta × Equity Risk Premium = 4.80% + 1.78 × 6.00% = 15.46% · WACC = weighted by 96%/4% capital structure
These numbers come from running Appen Limited's cash flows through the mechanical DCF formula and assumptions above — not from any view on the news, management, or APX.AX's competitive position. What is DCF?
Want to test your own growth or discount-rate assumptions?Open the full interactive calculator, pre-filled with APX.AX →
Not financial advice. DCF valuations are highly sensitive to assumptions — small changes in growth rate or discount rate produce large swings in output. This is a mechanical calculation, not a recommendation to buy, hold, or sell.
About this valuation
Computed on 2026-08-29 from Yahoo Finance data, using the same engine as the full DCF tool and the ASX 300 Most Undervalued screen. Every figure above is a point-in-time snapshot of that date — change any assumption yourself in the interactive tool for a live one.
Frequently asked questions
Is Appen Limited (APX.AX) undervalued?
The Base-case DCF estimates intrinsic value at $1.19 vs a price of $1.23 on 2026-08-29 — a -3.3% margin, so the Base case reads fairly valued. This is a mechanical output, not advice.